AGP Executive Report
Last update: 8 hours agoHIV Prevention in Maputo: Mozambique’s Maputo City is seeing strong uptake of long-acting injectable PrEP, with parliamentarians told that lenacapavir users are choosing the option that needs only two doses per year, easing clinic visits while keeping protection high. Diabetes Forecast: New EASD research projects type 1 diabetes will rise worldwide from 9.4 million people in 2025 to 12.1 million by 2049 (+29%), with the biggest relative growth in low-income countries including parts of Africa. Mining Health Claims: The Tshiamiso Trust says silicosis and work-related TB claims are accelerating, reporting a 64% jump in claim lodgements to 13,337 and continued benefit medical exams and compensation for eligible mineworkers and dependents. Public Health Access & Safety: A US travel advisory again urges Americans to avoid northern Mozambique, citing terrorism risk and also warning that health services can be limited, with variable medicine availability and possible cash payments upfront. Medicines Regulation Boost: Mozambique is highlighted for achieving WHO ML3 status for a well-functioning regulatory system for medicines, supporting safer access to drugs and vaccines. Food & Fertiliser Shock: Commentary on Africa’s fertiliser crisis links higher global urea prices to disrupted shipping, stressing the need for resilience beyond subsidies—so farmers aren’t hit as hard by import price swings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.